QA: PROCYON CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000812306_2023_PROCYON_CORP.pdf

Logs

Graph

Absolute values for 0000812306, PROCYON CORP

  xvar xval
0 AssetsCurrent 2,585,054
1 IntangibleAssetsNetIncludingGoodwill 17,000
2 PropertyPlantAndEquipmentNet 153,702
3 remainder_Assets 1,046,741
4 LiabilitiesCurrent 643,231
5 LiabilitiesNoncurrent 491,312
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,356,612
8 SellingGeneralAndAdministrativeExpense 1,710,606
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,986,809
11 remainder_Revenues 4,842,433
12 remainder_NetIncome 1,804
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,802,497
1 Liabilities 1,134,543
2 Expenses 5,054,027
3 Revenues 4,842,433
4 StockholdersEquity 2,667,954
5 NetIncome -209,790
6 ComprehensiveNetIncome -209,790
7 BaseVar 7,417,652
8 EconomicCapitalRatio 1.77

Edgar->Model Mapping

Feature Distribution

Change over Time